MS
Michael Schmitz Guggenheim Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.2B
| $37.88 | $45 |
19%
upside
| Buy | 1 month ago |
|
2
Revolution Medicines
RVMD
$7.57B
| $40.50 | $82 |
102%
upside
| Buy | 10 months ago |
|
3
Merus
MRUS
$5.1B
| $67.47 | $111 |
65%
upside
| Buy | 11 months ago |
|
4
Arvinas
ARVN
$575M
| $7.83 | $40 |
411%
upside
| Buy | 1 year ago |
|